Bizarre Patents
A small umbrella which may be removably attached to a beverage container in order to shade the beverage container from the direct rays of the sun.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7323592 | Methods for crystallization of hydroxycarboxylic acids The invention aims at producing high-purity crystals of a hydroxycarboxylic acid represented by the following formula (1): in high yield. Provided are a method for crystallization of a compound (1) which ... | 01/29/2008 |
| 7226951 | Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same Compounds of formulas 1 through 17 provided in the specification specifically or selectively inhibit either the cytochrome P450RAI-1 enzyme or the cytochrome P450RAI-2 enzyme. ... | 06/05/2007 |
| 7034180 | Method for crystallization of hydroxycarboxylic acids The invention aims at producing high-purity crystals of a hydroxycarboxylic acid represented by the following formula (1): in high yield. Provided are a method for crystallization of a compound (1) which compris... | 04/25/2006 |
| 6987193 | Illudin analogs useful as antitumor agents The present invention provides illudin analogs of the general formula (I): where R1 is (CH2)n—X—Y or H; n is 0 to 4; X is O or S or N or absent; and Y is an... | 01/17/2006 |
| 6878723 | LTA4 hydrolase inhibitors The invention concerns compounds inhibiting LTA4 hydrolase of formula (I). The invention also concerns their therapeutic, in particular anti-inflammatory, applications. ... | 04/12/2005 |
| 6861554 | Creatine salt having enhanced nutritional and therapeutic efficacy and compositions containing same A novel salt, creatine taurinate, and the compositions containing same (health foods, dietary supplements or drugs) are disclosed. ... | 03/01/2005 |
| 6835751 | Bicyclic amino acids as pharmaceutical agents The compounds of the instant invention are bicyclic amino acids useful in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, arthritis, neuropathological disorders, and sleep d... | 12/28/2004 |
| 6613932 | Prostaglandin derivatives A prostaglandin derivative represented by the formula: ##STR1## [wherein X is CH2, O or S(O)q1, Y is an ethylene group, a vinylene group, an ethynylene group, O(CH2)t1 or S(O)q2 (CH2)t... | 09/02/2003 |
| 6610743 | Bicyclic metabotropic glutamate receptor ligands The present invention provides bicyclic metabotropic glutamate receptor ligands, as well as compositions comprising such ligands, and and methods for their use.... | 08/26/2003 |
| 6576786 | Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof The invention relates to a process for preparing substituted cyclopentane derivatives represented by the formula (I) ##STR1## wherein R1, R2, R3, R4, X and Y are as described in the specification, and pharmaceut... | 06/10/2003 |
| 6392086 | Intermediates and process for producing fluorine-containing amino acid compound by using the same The present inventions relate to a (1S,5R,6S)- or (1SR, 5RS, 6SR)-3-fluoro-2-oxobicyclo[3.1.0]hex-3-ene-6-carboxylic acid derivative represented by Formula (1): ##STR1## [in the formula, R represents OR1 or NR1 R2, wherein... | 05/21/2002 |
| 6388128 | Stannane synthesis of prostanoids The present invention is directed to novel methods of prostanoid synthesis. Specifically, the invention is directed to the addition of alpha chains to prostanoids using cis-alkenylstannane intermediates.... | 05/14/2002 |
| 6344581 | Method of prostaglandin synthesis Methods of synthesizing 9-Halo-13,14-dihydroprostaglandins useful in the treatment of glaucoma and ocular hypertension are disclosed. Also disclosed are ophthalmic, pharmaceutical compositions comprising such prostaglandins.... | 02/05/2002 |
| 6337064 | Manganese chelates with high relaxivity in serum Compounds of formula (I) both in the racemic and optically active forms, are used in MRI diagnostic imaging. ##STR1##... | 01/08/2002 |
| 6232344 | 13-Oxa prostaglandins for the treatment of glaucoma and ocular hypertension 13-Oxa analogs of certain prostaglandins and methods of their use in treating glaucoma and ocular hypertension are disclosed.... | 05/15/2001 |
| 6204292 | Bicyclic metabotropic glutamate receptor ligands The present invention provides bicyclic metabotropic glutamate receptor ligands, as well as compositions comprising such ligands, and and methods for their use.... | 03/20/2001 |
| 6136861 | Bicyclo[2.2.1]heptanes and related compounds The present invention relates to compounds of the formula I, as defined in the specification, pharmaceutical compositions containing such compounds the use of such compounds to treat neurological and psychiatric disorders.... | 10/24/2000 |
| 6110969 | Cycloalkyl-prostaglandin E2 derivatives A ω-cycloalkyl-prostaglandin E2 derivatives of the formula (I) ##STR1## wherein R is carboxy or hydroxymethyl; R1 is oxo, methylene or halogen atom; R2 is H, OH or C1-4 alkoxy; R3 is H, C1-8 alkyl, C2-8 al... | 08/29/2000 |
| 6103925 | Dimethyl-substituted cyclohexane diene derivatives The present invention relates to dimethyl-substituted cyclohexanediene derivatives, to a process for their preparation, to their use as pharmaceuticals and to corresponding pharmaceuticals.... | 08/15/2000 |
| 6099824 | Benzyloxy derivatives of DTPA for MRI Compounds which can chelate paramagnetic bi- and trivalent metal ions, their chelates with said metal ions and their use as contrast agents in magnetic resonance imaging (MRI), the compounds having formula (I) ##STR1## wherein R is a --(CH2 | 08/08/2000 |
| 6040462 | Calix[4 ]arene dibenzo crown ethers, their preparation process and their use for the selective extraction of cesium ion Novel calix[4]arene dibenzo crown ethers useful to selectively extract cesium are represented by the formula: wherein R is a C1 -C10 normal alkyl, a phenyl or a methoxyphenyl, R' is hydrogen, p-tert-butyl or a C1 -C10... | 03/21/2000 |
| 6020370 | Bridged cyclic amino acids as pharmaceutical agents Bridged cyclic amino acids of formula ##STR1## are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological... | 02/01/2000 |
| 5912248 | Excitatory amino acid receptor antagonists Compounds of the formula ##STR1## in which X represents a bond, S, SO or SO2 ; and R is as defined in the specification are useful as modulators of metabotropic glutamate receptor function.... | 06/15/1999 |
| 5783602 | Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents The invention relates to leukotriene-B4 derivatives of general formula I, ##STR1## in which R1 represents CH2 OH, CH3, CF3 COOR4 CONR5 R6, and R3 symbo... | 07/21/1998 |
| 5756818 | 9-chloro-prostaglandin derivatives The invention relates to 9-chloro-prostaglandin derivatives of formula I ##STR1## in which X means oxygen or CH2, R1 means hydrogen or straight-chain or branched alkyl with 1-6 C atoms and A means trans-CH.dbd.CH-- or --CH2 | 05/26/1998 |
| 5726320 | Preparation of bicyclohexane derivative A process for the preparation of (+)-2-amino-bicyclo3.1.0!-hexane-2-6-dicarboxylic acid, or a pharmaceutically acceptable salt thereof, which comprises hydrolysing (-)-2-spiro-5'-hydantoinbicyclo3.1.0!hexane-6-carboxylic acid or a salt thereof, a... | 03/10/1998 |
| 5723494 | Derivatives of glutamic and aspartic acids, a method of preparing them, and their use as drugs for enhancing memory and learning Compounds represented by general formula (I) and (II), in which r is 1 or 2, R2 and R3 are selected independently from H, CH3, C2 H5 and CHO, provided that R2 and R3 are not simu... | 03/03/1998 |
| 5686621 | Substituted hydrindanes for the treatment of angiogenesis-dependent diseases Substituted hydrindanes and their use in controlling angiogenesis-dependent diseases in warm blooded animals are disclosed.... | 11/11/1997 |
| 5639894 | Carbonylation of allylic alcohols and synthesis of an ambergris fragrance compound A process for the carbonylation of allylic alcohols such as nerolidol, farnesol, or their monocyclic analogues with carbon monoxide at a pressure of at least 30 bar in the presence of a polar solvent and a palladium halide catalyst, optionally an alkali m... | 06/17/1997 |
| 5545666 | Prostaglandin derivatives A prostaglandin derivative represented by formula ##STR1## wherein R1 represents a hydrogen atom or a C1 -C6 alkyl group, and R2 represents a cyclohexyl group or a cyclopentylmethyl group. This compound has... | 08/13/1996 |
| 5464866 | Substituted hydrindanes for the treatment of angiogenesis-dependent diseases Substituted hydrindanes and their use in controlling angiogenesis-dependent diseases in warm blooded animals are disclosed.... | 11/07/1995 |
| 5449684 | Cytotoxic compounds Compounds isolated from a marine sponge, and derivatives thereof, have the formulae: ##STR1## in which R1 is H or lower alkyl; R2 is OH or CH3 ; R3 is OH or CH3, and R4 H or MPTA. The ... | 09/12/1995 |
| 5340828 | Inhibitors of farnesyl protein transferase The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invent... | 08/23/1994 |
| 5340835 | Esters of 2,2-dimethyl-3-[(2,2-difluoro-cyclopropylidene) methyl]cyclopropane carboxylic acids A compound selected from the group consisting of all stereoisomeric forms and mixtures thereof of a compound of the formula ##STR1## wherein Y and Z are individually selected from the groups consisting of hydrogen, halogen, --CF3, alkyl, a... | 08/23/1994 |
| 5228898 | Substituted bicycloheptandione derivatives This invention relates to substituted bicycloheptadione derivatives with high herbicidal activity which are represented by general formula (I) ##STR1## (where R1 is a lower alkyl group, a phenyl group which may be substituted, an aralkyl g... | 07/20/1993 |
| 5177251 | Halogenated tetraenyl prostaglandin derivatives The present invention relates to a novel class of halogenated tetraenyl prostaglandin compounds represented by the following general formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein Y is --CH.dbd.CH-- or --CH2 --CH2... | 01/05/1993 |
| 5177109 | 2-amino-4,5-methyleneadipic acid compounds for treatment of CNS disorders Compounds, compositions and methods are described for treating a CNS disorder such as a cognitive disorder, epilepsy, depression, Parkinson's disease, Alzheimer's disease, a neurodegenerative disease or neurotoxic injury. Compound of interest are 2-amino-... | 01/05/1993 |
| 5142099 | Enantioselective process An enantioselective process for the preparation of hemicaronic aldehyde with a cis or trans structure and novel intermediates.... | 08/25/1992 |
| 5130468 | Process for the preparation of a dipeptide isostere A process and intermediates useful for the preparation of (E)-alkene dipeptide isosteres are disclosed.... | 07/14/1992 |
| 5095137 | Amides of cyclomethylen-1,2-bicarboxylic acids having therapeutical activity The amides of cyclomethylen-1,2-bicarboxylic acids having the formula: ##STR1## wherein A represents ##STR2## R1 represents --H, --CH3, --CH2 --CH3, --CH(CH3)2, ##STR3## ... | 03/10/1992 |
